View : 805 Download: 0
Aberrant single-minded homolog 1 methylation as a potential biomarker for cervical cancer
- Title
- Aberrant single-minded homolog 1 methylation as a potential biomarker for cervical cancer
- Authors
- Kim H.-J.; Kim C.Y.; Jin J.; Bae M.K.; Kim Y.H.; Ju W.; Kim S.C.
- Ewha Authors
- 김승철; 주웅; 김윤환
- SCOPUS Author ID
- 김승철; 주웅; 김윤환
- Issue Date
- 2018
- Journal Title
- Diagnostic Cytopathology
- ISSN
- 8755-1039
- Citation
- Diagnostic Cytopathology vol. 46, no. 1, pp. 15 - 21
- Keywords
- cervical cancer; circulating cell-free DNA; diagnostic biomarker; DNA methylation; single-minded homolog 1(SIM1)
- Publisher
- John Wiley and Sons Inc.
- Indexed
- SCIE; SCOPUS
- Document Type
- Article
- Abstract
- Background: The aim of this study is to evaluate the possibility of using the methylation status of single-minded homolog 1 (SIM1) as a diagnostic biomarker for cervical cancer. Methods: All the patient and normal specimens including the normal cervix (n = 10), cervical cancer tissues (n = 45), blood (n = 45), and cervical brush specimens (n = 110) were retrospectively obtained. Quantitative methylation-specific PCR was performed to detect SIM1 methylation in primary tumors, cervical brush specimens, and plasma circulating cell-free DNA (ccfDNA). SIM1 expression was detected by western blot analysis. Results: We found that SIM1 was highly methylated in the majority of the cervical cancer tissues that we tested, but not in any of the normal tissues. Hypermethylation of SIM1 led to a pronounced reduction in SIM1 expression in cervical cancer tissues compared with normal cervix. SIM1 methylation status on cervical brush specimens also distinguished cervical cancer from normal, cervical intraepithelial neoplasia (CIN) 1 and 2. The degree of SIM1 methylation was significantly associated with the severity of the disease (Ptrend <.0001). We also investigated the possibility of detecting methylated SIM1 in plasma ccfDNA from cervical cancer patients. Methylated SIM1 was detected in 36.6% (15/41) of ccfDNA samples, and concordance rate with the matched cancer tissues was 41.5% (17/41) with sensitivity 38.5% and specificity 100%. Conclusion: This study has shown that SIM1 is frequently hypermethylated in cervical cancer, compared with normal cervix tissue, CIN1 and 2 samples, suggesting that the methylation status of SIM1 could be a potential diagnostic biomarker for cervical cancer. © 2017 Wiley Periodicals, Inc.
- DOI
- 10.1002/dc.23838
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML